➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Express Scripts
Johnson and Johnson
Baxter
McKinsey

Last Updated: August 4, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,789,270


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,789,270
Title:Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized
Abstract: An inhalation therapy device includes an atomizer for atomizing a drug which is advantageously present in the form of a fluid into an atomization chamber so that an aerosol or mist is provided in the atomization chamber. The patient or user can inhale the aerosol produced by the atomizer from the atomization chamber via a mouthpiece. The ampoule is inserted into an ampoule holder holding the fluid-containing ampoule. The inhalation therapy device also includes an opening unit for opening the fluid-containing ampoule. The ampoule holder advantageously includes a first part, disposed displaceably in relation to the opening unit, thereby allowing an ampoule present in the ampoule holder to be displaced in the direction of the opening unit.
Inventor(s): Hetzer; Uwe (Munich, DE), Gallem; Thomas (Munich, DE)
Assignee: PARI Pharma GmbH (Starnberg, DE)
Application Number:11/990,474
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 9,789,270

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,789,270

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2005 038 619Aug 16, 2005
PCT Information
PCT FiledAugust 16, 2006PCT Application Number:PCT/EP2006/008086
PCT Publication Date:February 22, 2007PCT Publication Number: WO2007/020073

International Family Members for US Patent 9,789,270

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2006281561 ⤷  Free Forever Trial
Brazil PI0614818 ⤷  Free Forever Trial
Canada 2619605 ⤷  Free Forever Trial
China 101291699 ⤷  Free Forever Trial
Germany 102005038619 ⤷  Free Forever Trial
European Patent Office 1919542 ⤷  Free Forever Trial
European Patent Office 3375474 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Moodys
Boehringer Ingelheim
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.